FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Joseph Sparano

Research Profile

Procedures

Disorders

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Lawrence J Solin; Joseph A Sparano; William C Wood; Carl Yoshizawa; Frederick L Baehner; Steven M Butler; Diana B Cherbavaz; Nancy E Davidson; Robert Gray; Lorie L Hughes; James N Ingle; David L Page; Edith A Perez; Steven Shak; George W Sledge; Sunil Badve
A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast.
Yihong Wang; Susan Fineberg; Susan Band Horwitz; Joseph A Sparano; Lesley Stead; Jaya Sunkara; Hayley M McDaid
High expression of class III β-tubulin predicts good response to neoadjuvant taxane and doxorubicin/cyclophosphamide-based chemotherapy in estrogen receptor-negative breast cancer.
Della Makower; Joseph A Sparano
How do I treat inflammatory breast cancer?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Joseph Sparano (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Lawrence J Solin; Joseph A Sparano; William C Wood; Carl Yoshizawa; Frederick L Baehner; Steven M Butler; Diana B Cherbavaz; Nancy E Davidson; Robert Gray; Lorie L Hughes; James N Ingle; David L Page; Edith A Perez; Steven Shak; George W Sledge; Sunil Badve
A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast.
Journal of the National Cancer Institute 2013;105(10):701-10.
2013: Yihong Wang; Susan Fineberg; Susan Band Horwitz; Joseph A Sparano; Lesley Stead; Jaya Sunkara; Hayley M McDaid
High expression of class III β-tubulin predicts good response to neoadjuvant taxane and doxorubicin/cyclophosphamide-based chemotherapy in estrogen receptor-negative breast cancer.
Clinical breast cancer 2013;13(2):103-8.
2013: Della Makower; Joseph A Sparano
How do I treat inflammatory breast cancer?
Current treatment options in oncology 2013;14(1):66-74.
2012: Joseph A Sparano; Vered Stearns; Molin Wang; Antonio C Wolff; William C Wood; Fengmin Zhao; John H Fetting; Jennifer A Ligibel; Silvana Martino; Edith A Perez; Tom Saphner; George W Sledge; Nancy E Davidson
Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancer.
Cancer 2012;118(23):5937-46.
2012: Linda Vahdat; Louise Yelle; Henri H Roché; Joseph A Sparano; Eva S Thomas; Craig A Bunnell; Monica Fornier; Gabriel N Hortobagyi; Miguel Martín; Pralay Mukhopadhyay; Ronald A Peck; Edith A Perez
Ixabepilone-associated peripheral neuropathy: data from across the phase II and III clinical trials.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2012;20(11):2661-8.
2012: Murali Janakiram; Joseph A Sparano; Yael M Abadi; Xingxing Zang
T cell coinhibition and immunotherapy in human breast cancer.
Discovery medicine 2012;14(77):229-36.
2012: Eugene J Fine; Silvia Herszkopf; Abdissa Negassa; Maria C Romano; Carol-Jane Segal-Isaacson; Amanda F Bontempo; Richard D Feinman; Norica Tomuta; Joseph A Sparano
Targeting insulin inhibition as a metabolic therapy in advanced cancer: a pilot safety and feasibility dietary trial in 10 patients.
Nutrition (Burbank, Los Angeles County, Calif.) 2012;28(10):1028-35.
2012: Stefan K Barta; Lawrence D Kaplan; Jeannette Y Lee; Ariela Noy; Joseph A Sparano
Pooled analysis of AIDS malignancy consortium trials evaluating rituximab plus CHOP or infusional EPOCH chemotherapy in HIV-associated non-Hodgkin lymphoma.
Cancer 2012;118(16):3977-83.
2012: Vicente Valero; Eduard Vrdoljak; Binghe Xu; Eva Thomas; Linda Vahdat; Linda Bosserman; Henry Gómez; Rubi Khaw Li; Alexey Manikhas; Carlos Medina; Pralay Mukhopadhyay; Diane Opatt; Jungsil Ro; Joseph A Sparano
Maintenance of clinical efficacy after dose reduction of ixabepilone plus capecitabine in patients with anthracycline- and taxane-resistant metastatic breast cancer: a retrospective analysis of pooled data from 2 phase III randomized clinical trials.
Clinical breast cancer 2012;12(4):240-6.
2012: Joseph A Sparano; George W Sledge; Nancy E Davidson; Lori J Goldstein; Robert Gray
TOP2A RNA expression and recurrence in estrogen receptor-positive breast cancer.
Breast cancer research and treatment 2012;134(2):751-7.
2012: Lawrence J Solin; Sunil Badve; Frederick L Baehner; Nancy E Davidson; Lori J Goldstein; Robert Gray; Silvana Martino; Edith A Perez; Abram Recht; Steven Shak; Lawrence N Shulman; George W Sledge; Joseph A Sparano
Prognostic value of biologic subtype and the 21-gene recurrence score relative to local recurrence after breast conservation treatment with radiation for early stage breast carcinoma: results from the Eastern Cooperative Oncology Group E2197 study.
Breast cancer research and treatment 2012;134(2):683-92.
2012: Tianhong Li; Edith A Perez; William J Gradishar; Mengye Guo; Joseph A Sparano; Molin Wang; George W Sledge
A phase II trial of capecitabine in combination with the farnesyltransferase inhibitor tipifarnib in patients with anthracycline-treated and taxane-resistant metastatic breast cancer: an Eastern Cooperative Oncology Group Study (E1103).
Breast cancer research and treatment 2012;134(1):345-52.
2012: Orsi Giricz; David N Krag; Stephanie C Pero; Joseph A Sparano; Verónica Calvo; Paraic A Kenny
GRB7 is required for triple-negative breast cancer cell invasion and survival.
Breast cancer research and treatment 2012;133(2):607-15.
2012: Adam M Petrich; Joseph A Sparano; Venu K Thirukonda; Netha Ulahannan; Bing Xia; B Hilda Ye; Melissa Fazzari; Shanisha Gordon; Pei-Yu Kuo; Violetta V. Leshchenko; Samir Parekh
Akt inhibitors MK-2206 and nelfinavir overcome mTOR inhibitor resistance in diffuse large B-cell lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(9):2534-44.
2012: Bhuvaneswari Ramaswamy; Charles L Shapiro; G Somlo; Vered Stearns; R Swaby; K Bhalla; P Christos; E Chuang; B Cohen; Igor Espinoza-Delgado; Warren C Fiskus; M Goetz; D L Hershman; Thehang Luu; C Pellegrino; Joseph A Sparano
Phase I-II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo.
Breast cancer research and treatment 2012;132(3):1063-72.
2012: Joseph A Sparano; Vered Stearns; Molin Wang; Antonio C Wolff; William C Wood; Fengmin Zhao; Jennifer A Ligibel; Silvana Martino; Edith A Perez; Tom Saphner; George W Sledge; Nancy E Davidson
Race and hormone receptor-positive breast cancer outcomes in a randomized chemotherapy trial.
Journal of the National Cancer Institute 2012;104(5):406-14.
2012: Adam M Petrich; Joseph A Sparano; Samir Parekh
Paradigms and Controversies in the Treatment of HIV-Related Burkitt Lymphoma.
Advances in hematology 2012;2012():403648.
2011: Joseph A Sparano; Lawrence N Shulman; Paraic Kenny; George W Sledge; Diana Brassard; Lori J Goldstein; Roberto Bugarini; Steven Shak; Silvana Martino; Sunil Badve; Steve Rowley; Barrett H Childs; Nancy E Davidson; Frederick L Baehner; Edith A Perez; Robert Gray
Relationship between quantitative GRB7 RNA expression and recurrence after adjuvant anthracycline chemotherapy in triple-negative breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(22):7194-203.
2011: Richard S Finn; Justin Fairchild; Henri Roché; Lewis C Strauss; Nuhad Ibrahim; Oumar Sy; Joseph A Sparano; Carmelo Bengala; Lori J Goldstein
Dasatinib as a single agent in triple-negative breast cancer: results of an open-label phase 2 study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(21):6905-13.
2011: Erica L Mayer; Ahmad Awada; Joseph A Sparano; Oumar Sy; Pierre Fumoleau; Hope Rugo; Mario Campone; Jean-Francois Baurain; Lewis Strauss; Antonio Llombart-Cussac
A phase 2 trial of dasatinib in patients with advanced HER2-positive and/or hormone receptor-positive breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(21):6897-904.
2011: Lakshmi Rajdev; Qun Dai; Gary L Goldberg; Kathy Miller; Abdissa Negassa; Joseph A Sparano
Phase I trial of metronomic oral vinorelbine in patients with advanced cancer.
Cancer chemotherapy and pharmacology 2011;68(5):1119-24.
2011: Joseph A Sparano; Howard D Strickler
Breast cancer patients who are obese at diagnosis: alea iacta est? or "is the die cast"?
Oncology (Williston Park, N.Y.) 2011;25(11):1002, 1004, 1007.
2011: Ayca Gucalp; Clifford Hudis; Joan Massague; Larry Norton; Sujata Patil; Christine Pellegrino; Jean Santamauro; Joseph A Sparano; Maria Theodoulou-Haber; Alyson Abbruzzi; Jackie Bromberg; James Caravelli; Chau Dang; Tiffany A Traina
Phase II trial of saracatinib (AZD0530), an oral SRC-inhibitor for the treatment of patients with hormone receptor-negative metastatic breast cancer.
Clinical breast cancer 2011;11(5):306-11.
2011: Mary Cianfrocca; Bruce J Dezube; Susan E Krown; Sandra Lee; MICHELLE RUDEK-RENAUT; Jamie H Von Roenn; Joseph A Sparano
Pilot study evaluating the interaction between paclitaxel and protease inhibitors in patients with human immunodeficiency virus-associated Kaposi's sarcoma: an Eastern Cooperative Oncology Group (ECOG) and AIDS Malignancy Consortium (AMC) trial.
Cancer chemotherapy and pharmacology 2011;68(4):827-33.
2011: Joseph A Sparano
Joseph Sparano on gene expression assays for breast cancer.
Oncology (Williston Park, N.Y.) 2011;25(10):947.
2011: Allyson J Ocean; Abby Siegel; Joseph A Sparano; Max Sung; Maureen M Ward; Yun Yen; Paul Christos; Igor Espinoza-Delgado; Nancy Hamel; Andreas Kaubish; Dan Matulich; Maureen E Lane
Phase II trial of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehydethiosemicarbazone plus gemcitabine in patients with advanced biliary tract cancer.
Cancer chemotherapy and pharmacology 2011;68(2):379-88.
2011: Eleni Andreopoulou; Joseph A Sparano
Seeing red: anthracyclines for breast cancer.
Oncology (Williston Park, N.Y.) 2011;25(2):128, 131, 134.
2011: Henri Roché; Pierfranco Conte; Edith A Perez; Joseph A Sparano; Binghe Xu; Jacek Jassem; Ronald Peck; Thomas Kelleher; Gabriel N Hortobagyi
Ixabepilone plus capecitabine in metastatic breast cancer patients with reduced performance status previously treated with anthracyclines and taxanes: a pooled analysis by performance status of efficacy and safety data from 2 phase III studies.
Breast cancer research and treatment 2011;125(3):755-65.
2011: Ruben Niesvizky; Scott Ely; Tomer Mark; Sangeeta Aggarwal; Janice L Gabrilove; John J Wright; Selina Chen-Kiang; Joseph A Sparano
Phase 2 trial of the histone deacetylase inhibitor romidepsin for the treatment of refractory multiple myeloma.
Cancer 2011;117(2):336-42.
2010: Allyson J Ocean; Blase Polite; Paul Christos; Lisa Horvath; Anne Hamilton; Daniel Matulich; Helen X Chen; Joseph A Sparano; Hedy L Kindler
Cetuximab is associated with excessive toxicity when combined with bevacizumab Plus mFOLFOX6 in metastatic colorectal carcinoma.
Clinical colorectal cancer 2010;9(5):290-6.
2010: Stephanie V Blank; Paul Christos; John P Curtin; Noah Goldman; Carolyn D Runowicz; Joseph A Sparano; Leonard Liebes; Helen X Chen; Franco M Muggia
Erlotinib added to carboplatin and paclitaxel as first-line treatment of ovarian cancer: a phase II study based on surgical reassessment.
Gynecologic oncology 2010;119(3):451-6.
2010: E Chuang; N Wiener; P Christos; R Kessler; M Cobham; D Donovan; Gary L Goldberg; T Caputo; A Doyle; L Vahdat; Joseph A Sparano
Phase I trial of ixabepilone plus pegylated liposomal doxorubicin in patients with adenocarcinoma of breast or ovary.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(10):2075-80.
2010: Mary Cianfrocca; Sandra Lee; Jamie H Von Roenn; Anil Tulpule; Bruce J Dezube; David M Aboulafia; Richard F Ambinder; Jeannette Y Lee; Susan E Krown; Joseph A Sparano
Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma: evidence of symptom palliation from chemotherapy.
Cancer 2010;116(16):3969-77.
2010: Joseph A Sparano
Is there a role for ovarian function suppression in operable breast cancer?
Breast cancer research and treatment 2010;123(1):311-3.
2010: Joseph A Sparano; Eduard Vrdoljak; Oliver Rixe; Binghe Xu; Alexey Manikhas; Carlos Medina; Susanne Crocamo Ventilari Da Costa; Jungsil Ro; Gonzalo Rubio; Monica Rondinon; Gumersindo Perez Manga; Ronald Peck; Valerie Poulart; Pierfranco Conte
Randomized phase III trial of ixabepilone plus capecitabine versus capecitabine in patients with metastatic breast cancer previously treated with an anthracycline and a taxane.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(20):3256-63.
2010: Joseph A Sparano; Melissa Fazzari; Paraic Kenny
Clinical application of gene expression profiling in breast cancer.
Surgical oncology clinics of North America 2010;19(3):581-606.
2010: Antonio C Wolff; Molin Wang; Hailun Li; Michael R Pins; Florence J Pretorius; Kendrith M Rowland; Joseph A Sparano; Nancy E Davidson
Phase II trial of pegylated liposomal doxorubicin plus docetaxel with and without trastuzumab in metastatic breast cancer: Eastern Cooperative Oncology Group trial E3198.
Breast cancer research and treatment 2010;121(1):111-20.
2010: Joseph A Sparano; Jeannette Y Lee; Lawrence D Kaplan; Alexandra M Levine; Juan Carlos Ramos; Richard F Ambinder; William Wachsman; David Aboulafia; Ariela Noy; David H Henry; Jamie Von Roenn; Bruce J Dezube; Scot C Remick; Manisha H Shah; Lawrence Leichman; Lee Ratner; Ethel Cesarman; Amy Chadburn; Ronald Mitsuyasu
Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma.
Blood 2010;115(15):3008-16.
2010: Joseph A Sparano; Lawrence J Solin
Defining the clinical utility of gene expression assays in breast cancer: the intersection of science and art in clinical decision making.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(10):1625-7.
2010: Joseph A Sparano; Etta D Pisano; Julia R White; Kelly K Hunt; Eleftherios P Mamounas; Edith A Perez; Gabriel N Hortobagyi; Julie R Gralow; Robert L Comis
Recommendations for research priorities in breast cancer by the coalition of cancer cooperative groups scientific leadership council: imaging and local therapy.
Breast cancer research and treatment 2010;120(2):273-84.
2010: Anthony P Lam; Joseph A Sparano; Vincent Vinciguerra; Allyson J Ocean; Paul Christos; Howard Hochster; Fernando Camacho; SANJAY GOEL; Sridhar Mani; Andreas Kaubisch
Phase II study of paclitaxel plus the protein kinase C inhibitor bryostatin-1 in advanced pancreatic carcinoma.
American journal of clinical oncology 2010;33(2):121-4.
2010: Stacy Moulder; Hailun Li; Molin Wang; William J Gradishar; Edith A Perez; Joseph A Sparano; Michael Pins; Ximing Yang; George W Sledge
A phase II trial of trastuzumab plus weekly ixabepilone and carboplatin in patients with HER2-positive metastatic breast cancer: an Eastern Cooperative Oncology Group Trial.
Breast cancer research and treatment 2010;119(3):663-71.
2010: Rachel Raab; Joseph A Sparano; Allyson J Ocean; Paul Christos; Mark Ramirez; Vincent Vinciguerra; Andreas Kaubisch
A phase I trial of oblimersen sodium in combination with cisplatin and 5-fluorouracil in patients with advanced esophageal, gastroesophageal junction, and gastric carcinoma.
American journal of clinical oncology 2010;33(1):61-5.
2010: Joseph A Sparano; Gabriel N Hortobagyi; Julie R Gralow; Edith A Perez; Robert L Comis
Recommendations for research priorities in breast cancer by the Coalition of Cancer Cooperative Groups Scientific Leadership Council: systemic therapy and therapeutic individualization.
Breast cancer research and treatment 2010;119(3):511-27.
2009: Amy Chadburn; April Chiu; Jeannette Y Lee; Xia Chen; Elizabeth Hyjek; Alison H Banham; Ariela Noy; Lawrence D Kaplan; Joseph A Sparano; Kishor Bhatia; Ethel Cesarman
Immunophenotypic analysis of AIDS-related diffuse large B-cell lymphoma and clinical implications in patients from AIDS Malignancies Consortium clinical trials 010 and 034.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(30):5039-48.
2009: Joseph A Sparano; Anatoly N Makhson; Vladimir F Semiglazov; Sergei A Tjulandin; Olga I Balashova; Igor N Bondarenko; Natalia V Bogdanova; George M Manikhas; Gennadiy P Oliynychenko; Valery A Chatikhine; Sen H Zhuang; Liang Xiu; Zhilong Yuan; Wayne R Rackoff
Pegylated liposomal doxorubicin plus docetaxel significantly improves time to progression without additive cardiotoxicity compared with docetaxel monotherapy in patients with advanced breast cancer previously treated with neoadjuvant-adjuvant anthracycline therapy: results from a randomized phase III study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(27):4522-9.
2009: Joseph A Sparano; Stacy Moulder; Aslamuzzaman Kazi; Domenico Coppola; Abdissa Negassa; Linda Vahdat; Tianhong Li; Christine Pellegrino; Susan Fineberg; Pam Munster; Mokenge Malafa; David Lee; Shira Hoschander; Una Hopkins; Dawn Hershman; John J Wright; Celina G Kleer; Sofia D Merajver; Said M Sebti
Phase II trial of tipifarnib plus neoadjuvant doxorubicin-cyclophosphamide in patients with clinical stage IIB-IIIC breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(8):2942-8.
2009: Tianhong Li; P J Christos; Joseph A Sparano; Dawn Hershman; S Hoschander; K O'Brien; J J Wright; Linda Vahdat
Phase II trial of the farnesyltransferase inhibitor tipifarnib plus fulvestrant in hormone receptor-positive metastatic breast cancer: New York Cancer Consortium Trial P6205.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(4):642-7.
2009: Christine B Ambrosone; Gregory L Ciupak; Elisa V Bandera; Lina Jandorf; Dana H Bovbjerg; Gary Zirpoli; Karen Pawlish; James Godbold; Anna Furberg-Barnes; Anne Fatone; Heiddis Valdimarsdottir; Song Yao; Yulin Li; Helena Hwang; Warren Davis; Michelle Roberts; Lara Sucheston; Kitaw Demissie; Kandace L Amend; Paul Tartter; James Reilly; Benjamin W Pace; Thomas E Rohan; Joseph A Sparano; George Raptis; Maria Castaldi; Alison Estabrook; Sheldon Feldman; Christina Weltz; Margaret Kemeny
Conducting Molecular Epidemiological Research in the Age of HIPAA: A Multi-Institutional Case-Control Study of Breast Cancer in African-American and European-American Women.
Journal of oncology 2009;2009():871250.
2009: Lee Ratner; William J Harrington; Xuan Feng; Christian Grant; Steve Jacobson; Ariela Noy; Joseph A Sparano; Jeannette Lee; Richard F Ambinder; Nancy Campbell; Michael Lairmore
Human T cell leukemia virus reactivation with progression of adult T-cell leukemia-lymphoma.
PloS one 2009;4(2):e4420.
2008: Carlos L Arteaga; Anne O'Neill; Stacy L Moulder; Michael Pins; Joseph A Sparano; George W Sledge; Nancy E Davidson
A phase I-II study of combined blockade of the ErbB receptor network with trastuzumab and gefitinib in patients with HER2 (ErbB2)-overexpressing metastatic breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(19):6277-83.
2008: Lori J Goldstein; Robert Gray; Sunil Badve; Barrett H Childs; Carl Yoshizawa; Steve Rowley; Steven Shak; Frederick L Baehner; Peter M Ravdin; Nancy E Davidson; George W Sledge; Edith A Perez; Lawrence N Shulman; Silvana Martino; Joseph A Sparano
Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(25):4063-71.
2008: Lori J Goldstein; Anne O'Neill; Joseph A Sparano; Edith A Perez; Lawrence N Shulman; Silvana Martino; Nancy E Davidson
Concurrent doxorubicin plus docetaxel is not more effective than concurrent doxorubicin plus cyclophosphamide in operable breast cancer with 0 to 3 positive axillary nodes: North American Breast Cancer Intergroup Trial E 2197.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(25):4092-9.
2008: Tianhong Li; Joseph A Sparano
Farnesyl transferase inhibitors.
Cancer investigation 2008;26(7):653-61.
2008: Sunil S Badve; Frederick L Baehner; Robert P Gray; Barrett H Childs; Tara Maddala; Mei-Lan Liu; Steve C Rowley; Steven Shak; Edith A Perez; Edith D Perez; Lawrence J Shulman; Silvana Martino; Nancy E Davidson; George W Sledge; Lori J Goldstein; Joseph A Sparano
Estrogen- and progesterone-receptor status in ECOG 2197: comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription polymerase chain reaction by central laboratory.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(15):2473-81.
2008: Joseph A Sparano; Molin Wang; Silvana Martino; Vicky Jones; Edith A Perez; Tom Saphner; Antonio C Wolff; George W Sledge; William C Wood; Nancy E Davidson
Weekly paclitaxel in the adjuvant treatment of breast cancer.
The New England journal of medicine 2008;358(16):1663-71.
2008: Joseph A Sparano; Soonmyung Paik
Development of the 21-gene assay and its application in clinical practice and clinical trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(5):721-8.
2007: John P Leonard; Brian K Link; Christos Emmanouilides; Stephanie A Gregory; Daniel Weisdorf; Jeffrey Andrey; John Hainsworth; Joseph A Sparano; Donald E Tsai; Sandra Horning; Arthur M Krieg; George J Weiner
Phase I trial of toll-like receptor 9 agonist PF-3512676 with and following rituximab in patients with recurrent indolent and aggressive non Hodgkin's lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(20):6168-74.
2007: Alyson B. Moadel; Chirag Shah; Judith Wylie-Rosett; Melanie S Harris; Sapana R Patel; Charles B Hall; Joseph A Sparano
Randomized controlled trial of yoga among a multiethnic sample of breast cancer patients: effects on quality of life.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(28):4387-95.
2007: Joseph A Sparano
HIV-associated lymphoma: the evidence for treating aggressively but with caution.
Current opinion in oncology 2007;19(5):458-63.
2007: Henri Roché; Louise Yelle; Francesco Cognetti; Louis Mauriac; Craig A Bunnell; Joseph A Sparano; Pierre Kerbrat; Jean-Pierre Delord; Linda Vahdat; Ronald Peck; David Lebwohl; Rana Ezzeddine; Hervé Curé
Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, as first-line therapy in patients with metastatic breast cancer previously treated with anthracycline chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(23):3415-20.
2007: Clifford Hudis; William E Barlow; Joseph P Costantino; Robert J Gray; Kathleen I Pritchard; Judith-Anne W Chapman; Joseph A Sparano; Sally Hunsberger; Rebecca A Enos; Richard D Gelber; Jo Anne Zujewski
Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(15):2127-32.
2006: Joseph A Sparano
TAILORx: trial assigning individualized options for treatment (Rx).
Clinical breast cancer 2006;7(4):347-50.
2006: Joseph A Sparano; Stacy Moulder; Aslamuzzaman Kazi; Linda Vahdat; Tianhong Li; Christine Pellegrino; Pamela N Munster; Mokenge Malafa; David Lee; Shira Hoschander; Una Hopkins; Dawn Hershman; John J Wright; Said M Sebti
Targeted inhibition of farnesyltransferase in locally advanced breast cancer: a phase I and II trial of tipifarnib plus dose-dense doxorubicin and cyclophosphamide.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(19):3013-8.
2006: Tianhong Li; Federica Sotgia; Magalis A Vuolo; Maomi Li; Wancai Yang; Richard G Pestell; Joseph A Sparano; Michael P Lisanti
Caveolin-1 mutations in human breast cancer: functional association with estrogen receptor alpha-positive status.
The American journal of pathology 2006;168(6):1998-2013.
2006: Rashna Madan; Robert Gormley; Alina Dulau; Dongsheng Xu; Daniel Walsh; K.H. Ramesh; Linda Cannizaro; Ecaterina F Tamas; Pankaj Kumar; Joseph A Sparano; Aaron LeValley; Xiaonan Xue; Pritish K Bhattacharyya; Harry L Ioachim; Howard Ratech
AIDS and non-AIDS diffuse large B-cell lymphomas express different antigen profiles.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2006;19(3):438-46.
2006: Stanley Zucker; Molin Wang; Joseph A Sparano; William J Gradishar; James N Ingle; Nancy E Davidson
Plasma matrix metalloproteinases 7 and 9 in patients with metastatic breast cancer treated with marimastat or placebo: Eastern Cooperative Oncology Group trial E2196.
Clinical breast cancer 2006;6(6):525-9.
2006: Lakshmi Rajdev; Gary L Goldberg; Una Hopkins; Joseph A Sparano
A phase I trial of gemcitabine administered as a 96-h continuous intravenous infusion in patients with advanced carcinoma and lymphoma.
Medical oncology (Northwood, London, England) 2006;23(3):369-76.
2005: Samir Parekh; Tiffany Hebert; Howard Ratech; Joseph A Sparano
Variable problems in lymphomas: CASE 3. Spontaneous regression of HIV-associated Burkitt's lymphoma of the cecum.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(31):8116-7.
2005: Robert P Gormley; Rashna Madan; Alina Dulau; Dongsheng Xu; Ecaterina F Tamas; Pritish K Bhattacharyya; Aaron LeValley; Xiaonan Xue; Pankaj Kumar; Joseph A Sparano; K.H. Ramesh; Venkat Pulijaal; Linda Cannizzaro; Daniel Walsh; Harry L Ioachim; Howard Ratech
Germinal center and activated b-cell profiles separate Burkitt lymphoma and diffuse large B-cell lymphoma in AIDS and non-AIDS cases.
American journal of clinical pathology 2005;124(5):790-8.
2005: Joseph A Sparano
Cancer in AIDS.
Current opinion in oncology 2005;17(5):446.
2005: Lawrence D Kaplan; Jeannette Y Lee; Richard F Ambinder; Joseph A Sparano; Ethel Cesarman; Amy Chadburn; Alexandra M Levine; David T Scadden
Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010.
Blood 2005;106(5):1538-43.
2005: Joseph A Sparano; Melissa Fazzari; Geoffrey Childs
Clinical application of molecular profiling in breast cancer.
Future oncology (London, England) 2005;1(4):485-96.
2005: Ruth O' REGAN; Jamie H Von Roenn; Robert W Carlson; Ummekalsoom Malik; Joseph A Sparano; Valerie L Staradub; Seema Khan; Borko Jovanovic; Monica Morrow; William J Gradishar
Final results of a phase II trial of preoperative TAC (docetaxel/doxorubicin/cyclophosphamide) in stage III breast cancer.
Clinical breast cancer 2005;6(2):163-8.
2005: Hyman Muss; Jamie H Von Roenn; Lloyd Earl Damon; Lisa De Angelis; Lawrence E Flaherty; Paul M Harari; Karen Kelly; Michael P Kosty; Matthew J Loscalzo; Robert Mennel; Beverly S Mitchell; Joanne E Mortimer; Franco Muggia; Edith A Perez; Peter W T Pisters; Leonard B Saltz; Lidia Schapira; Joseph A Sparano
ACCO: ASCO core curriculum outline.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(9):2049-77.
2005: Michele Spina; Ulrich Jaeger; Joseph A Sparano; Renato Talamini; Cecilia Simonelli; Mariagrazia Michieli; Giuseppe Rossi; Ezio Nigra; Massimiliano Berretta; Chiara Cattaneo; Armin C Rieger; Emanuela Vaccher; Umberto Tirelli
Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: pooled results from 3 phase 2 trials.
Blood 2005;105(5):1891-7.
2005: Joseph A Sparano; Abdissa Negassa; Erick Lansigan; Robin Locke; Chamath R De Silva; Peter H Wiernik
Phase I trial of infusional cyclophosphamide, doxorubicin, and etoposide plus granulocyte-macrophage colony stimulating factor (GM-CSF) in non-Hodgkin's lymphoma.
Medical oncology (Northwood, London, England) 2005;22(3):257-67.
2004: Nicholas J Robert; Charles L Vogel; I Craig Henderson; Joseph A Sparano; Melvin R Moore; Paula Silverman; Beth Overmoyer; Charles L Shapiro; John W Park; Gail T Colbern; Eric P Winer; Alberto Gabizon
The role of the liposomal anthracyclines and other systemic therapies in the management of advanced breast cancer.
Seminars in oncology 2004;31(6 Suppl 13):106-46.
2004: David S Alberts; Franco M Muggia; James Carmichael; Eric P Winer; Mohammad Jahanzeb; Alan P Venook; Keith M Skubitz; Edgardo Rivera; Joseph A Sparano; Nicholas J DiBella; Simon J Stewart; John J Kavanagh; Alberto Gabizon
Efficacy and safety of liposomal anthracyclines in phase I/II clinical trials.
Seminars in oncology 2004;31(6 Suppl 13):53-90.
2004: Joseph A Sparano; Patricia Bernardo; Patricia Stephenson; William J Gradishar; James N Ingle; Stanley Zucker; Nancy E Davidson
Randomized phase III trial of marimastat versus placebo in patients with metastatic breast cancer who have responding or stable disease after first-line chemotherapy: Eastern Cooperative Oncology Group trial E2196.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(23):4683-90.
2004: Joseph A Sparano; Sandra Lee; Michael G Chen; Tipu Nazeer; Avi Einzig; Richard F Ambinder; David H Henry; Jane Manalo; Tianhong Li; Jamie H Von Roenn
Phase II trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group Trial (E1494).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(8):1491-500.
2004: Kathy D Miller; Thomas J Saphner; David M Waterhouse; T-T Chen; Anita Rush-Taylor; Joseph A Sparano; Antonio C Wolff; Melody A Cobleigh; Susan Galbraith; George W Sledge
A randomized phase II feasibility trial of BMS-275291 in patients with early stage breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(6):1971-5.
2004: Joseph A Sparano; Robert Gray; Bruce Giantonio; Peter J O'Dwyer; Robert L Comis
Evaluating antiangiogenesis agents in the clinic: the Eastern Cooperative Oncology Group Portfolio of Clinical Trials.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(4):1206-11.
2004: Joshua P Raff; Lakshmi Rajdev; Ummekalsoom Malik; Yelena Novik; Jane M Manalo; Abdissa Negassa; Una Hopkins; Catherine Sarta; Joseph A Sparano
Phase II study of weekly docetaxel alone or in combination with trastuzumab in patients with metastatic breast cancer.
Clinical breast cancer 2004;4(6):420-7.
2003: Anu G Gaba; Joseph A Sparano
Metastatic carcinoma: an unusual cause of focal brain lesions in HIV infection.
The AIDS reader 2003;13(11):547-8, 551-3, 558-9.
2003: Joseph A Sparano
Human immunodeficiency virus associated lymphoma.
Current opinion in oncology 2003;15(5):372-8.
2003: Huda S Salman; Alejandra Perez; Joseph A Sparano; Howard Ratech; Abdissa Negassa; Una Hopkins; Gina Villani; Joachim Fuks; Peter H Wiernik
Phase II trial of infusional cyclophosphamide, idarubicin, and etoposide in poor prognosis non-Hodgkin's lymphoma.
American journal of clinical oncology 2003;26(4):338-43.
2003: Samir Parekh; Howard Ratech; Joseph A Sparano
Human immunodeficiency virus-associated lymphoma.
Clinical advances in hematology & oncology : H&O 2003;1(5):295-301.
2003: Della Makower; Joseph A Sparano; Scott Wadler; Karen Fehn; Leon Landau; Paul Wissel; Melissa Versola; Sridhar Mani
A pilot study of edrecolomab (Panorex, 17-1A antibody) and capecitabine in patients with advanced or metastatic adenocarcinoma.
Cancer investigation 2003;21(2):177-84.
2003: Tianhong Li; Joseph A Sparano
Inhibiting Ras signaling in the therapy of breast cancer.
Clinical breast cancer 2003;3(6):405-16; discussion 417-20.
2003: Michele Spina; Joseph A Sparano; Ulrich Jaeger; Giuseppe Rossi; Umberto Tirelli
Rituximab and chemotherapy is highly effective in patients with CD20-positive non-Hodgkin's lymphoma and HIV infection.
AIDS (London, England) 2003;17(1):137-8.
2003: Muhammad R Abbasi; Joseph A Sparano; Catherine Sarta; Peter H Wiernik
Phase I trial of fludarabine and paclitaxel in non-Hodgkin's lymphoma.
Medical oncology (Northwood, London, England) 2003;20(1):53-8.
2002: Kylie A Hotchkiss; Anthony W Ashton; Radma Mahmood; Robert G Russell; Joseph A Sparano; Edward L Schwartz
Inhibition of endothelial cell function in vitro and angiogenesis in vivo by docetaxel (Taxotere): association with impaired repositioning of the microtubule organizing center.
Molecular cancer therapeutics 2002;1(13):1191-200.
2002: Joseph A Sparano; Edie Weller; Tipu Nazeer; Thomas M Habermann; Ann E Traynor; Jane Manalo; Peter A Cassileth
Phase 2 trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with poor-prognosis, intermediate-grade non-Hodgkin lymphoma: an Eastern Cooperative Oncology Group trial (E3493).
Blood 2002;100(5):1634-40.
2002: Kathy D Miller; W Gradishar; L Schuchter; Joseph A Sparano; Melody A Cobleigh; N Robert; H Rasmussen; G W Sledge
A randomized phase II pilot trial of adjuvant marimastat in patients with early-stage breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(8):1220-4.
2002: Joseph A Sparano; David L Brown; Antonio C Wolff
Predicting cancer therapy-induced cardiotoxicity: the role of troponins and other markers.
Drug safety : an international journal of medical toxicology and drug experience 2002;25(5):301-11.
2002: Huda S Salman; Katie Tanaka; Joseph A Sparano
Phase I/II trial of gemcitabine plus cyclophosphamide in patients with metastatic breast carcinoma previously treated with taxanes.
Clinical breast cancer 2002;2(4):299-303.
2002: Umberto Tirelli; Michele Spina; U Jaeger; Ezio Nigra; P L Blanc; A M Liberati; A Benci; Joseph A Sparano
Infusional CDE with rituximab for the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: preliminary results of a phase I/II study.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 2002;159():149-53.
2001: Joseph A Sparano; Eric P Winer
Liposomal anthracyclines for breast cancer.
Seminars in oncology 2001;28(4 Suppl 12):32-40.
2001: Joseph A Sparano
Clinical aspects and management of AIDS-related lymphoma.
European journal of cancer (Oxford, England : 1990) 2001;37(10):1296-305.
2001: Joseph A Sparano; Ummekalsoom Malik; Lakshmi Rajdev; Catherine Sarta; Una Hopkins; Antonio C Wolff
Phase I trial of pegylated liposomal doxorubicin and docetaxel in advanced breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(12):3117-25.
2001: Anand K Sharma; Sridhar Mani; Nadar N Hanna; Chandan Guha; B Vikram; R R Weichselbaum; Joseph A Sparano; B Sood; David Lee; William F Regine; M Muhodin; Joseph Valentino; JOSEPH HERMAN; Philip Desimone; S Arnold; J Carrico; Anna Rockich; J Warner-Carpenter; M Barton-Baxter
Clinical protocol. An open-label, phase I, dose-escalation study of tumor necrosis factor-alpha (TNFerade Biologic) gene transfer with radiation therapy for locally advanced, recurrent, or metastatic solid tumors.
Human gene therapy 2001;12(9):1109-31.
2001: B Kalfon; SA Fineberg; Y Gu; K Anand; J Jones; Joseph A Sparano
Microvessel density and p53 overexpression in young women with breast cancer: a case-control study.
Clinical breast cancer 2001;2(1):67-72.
2001: Joseph A Sparano
Cardiac toxicity of trastuzumab (Herceptin): implications for the design of adjuvant trials.
Seminars in oncology 2001;28(1 Suppl 3):20-7.
2001: Joseph A Sparano; Gary Kalkut
Special considerations regarding antiretroviral therapy and infection prophylaxis in the HIV-infected individual with cancer.
Cancer treatment and research 2001;104():347-66.
2001: Richard F Ambinder; Joseph A Sparano
Primary central nervous system lymphoma.
Cancer treatment and research 2001;104():231-46.
2000: Joseph A Sparano; Antonio C Wolff; D Brown
Troponins for predicting cardiotoxicity from cancer therapy.
Lancet 2000;356(9246):1947-8.
2000: Brian T Zafonte; James Hulit; DF Amanatullah; Chris Albanese; Chenguang Wang; E Rosen; Anne T Reutens; Joseph A Sparano; Michael P Lisanti; Richard G Pestell
Cell-cycle dysregulation in breast cancer: breast cancer therapies targeting the cell cycle.
Frontiers in bioscience : a journal and virtual library 2000;5():D938-61.
2000: Joseph A Sparano; A O'Neill; P L Schaefer; C I Falkson; William C Wood
Phase II trial of doxorubicin and docetaxel plus granulocyte colony-stimulating factor in metastatic breast cancer: Eastern Cooperative Oncology Group Study E1196.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(12):2369-77.
2000: Joseph A Sparano
Taxanes for breast cancer: an evidence-based review of randomized phase II and phase III trials.
Clinical breast cancer 2000;1(1):32-40; discussion 41-2.
2000: Joseph A Sparano; Lakshmi Rajdev
Taxane-based therapy for breast cancer: combination or sequential therapy?
Cancer investigation 2000;18(5):498-500.
1999: Joseph A Sparano; P Hu; R M Rao; C I Falkson; Antonio C Wolff; William C Wood
Phase II trial of doxorubicin and paclitaxel plus granulocyte colony-stimulating factor in metastatic breast cancer: an Eastern Cooperative Oncology Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(12):3828-34.
1999: J Desai; R J Mitnick; David H Henry; Josefina F Llena; Joseph A Sparano
Patterns of central nervous system recurrence in patients with systemic human immunodeficiency virus-associated non-hodgkin lymphoma.
Cancer 1999;86(9):1840-7.
1999: Joseph A Sparano; K Anand; J Desai; R J Mitnick; Gary Kalkut; Lawrence Hanau
Effect of highly active antiretroviral therapy on the incidence of HIV-associated malignancies at an urban medical center.
Journal of acquired immune deficiency syndromes (1999) 1999;21 Suppl 1():S18-22.
1999: Joseph A Sparano
Doxorubicin/taxane combinations: cardiac toxicity and pharmacokinetics.
Seminars in oncology 1999;26(3 Suppl 9):14-9.
1999: Janis Racevskis; A Dill; Joseph A Sparano; H Ruan
Molecular cloning of LMO41, a new human LIM domain gene.
Biochimica et biophysica acta 1999;1445(1):148-53.
1999: Joseph A Sparano; James Speyer; William J Gradishar; Leonard Liebes; R Sridhara; S Mendoza; David Fry; Merrill J Egorin
Phase I trial of escalating doses of paclitaxel plus doxorubicin and dexrazoxane in patients with advanced breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(3):880-6.
1998: Joseph A Sparano
Compilation of phase I and II trial data of docetaxel and doxorubicin in the treatment of advanced breast cancer and other malignancies.
Seminars in oncology 1998;25(6 Suppl 13):10-5.
1998: R Katherine Alpaugh; Margaret von Mehren; I Palazzo; M B Atkins; Joseph A Sparano; L Schuchter; Louis M Weiner; Janice P Dutcher
Phase IB trial for malignant melanoma using R24 monoclonal antibody, interleukin-2/alpha-interferon.
Medical oncology (Northwood, London, England) 1998;15(3):191-8.
1998: Joseph A Sparano
Use of dexrazoxane and other strategies to prevent cardiomyopathy associated with doxorubicin-taxane combinations.
Seminars in oncology 1998;25(4 Suppl 10):66-71.
1998: Peter H Wiernik; Janice P Dutcher; Avi Einzig; Joseph A Sparano; M Frank; W Friedenberg
Mitoxantrone, vinblastine, and lomustine (CCNU) (MVC): a highly active regimen for advanced and poor-prognosis Hodgkin's disease.
The cancer journal from Scientific American 1998;4(4):254-60.
1998: BF Iskaros; X Hu; Joseph A Sparano; SA Fineberg
Tenascin pattern of expression and established prognostic factors in invasive breast carcinoma.
Journal of surgical oncology 1998;68(2):107-12.
1998: Joseph A Sparano; Peter H Wiernik; X Hu; Catherine Sarta; David H Henry; Howard Ratech
Saquinavir enhances the mucosal toxicity of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin's lymphoma.
Medical oncology (Northwood, London, England) 1998;15(1):50-7.
1998: K Hornbuckle; A Chak; Hillard M Lazarus; Gregory Scott Cooper; LA Kutteh; Rasim Gucalp; P S Carlisle; Joseph A Sparano; P Parker; Robert A Salata
Determination and validation of a predictive model for Clostridium difficile diarrhea in hospitalized oncology patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(3):307-11.
1998: R Seno; Joseph A Sparano; SA Fineberg
Gross and histologic features of locally advanced breast cancer after neoadjuvant chemotherapy.
Anatomic pathology (Chicago, Ill. : annual) 1998;3():169-80.
1997: Joseph A Sparano
Chemotherapy for AIDS-related lymphomas.
The New England journal of medicine 1997;337(16):1173; author reply 1173-4.
1997: G C Kabat; C J Chang; Joseph A Sparano; D W Sepkovie; XP Hu; A Khalil; R Rosenblatt; H Leon Bradlow
Urinary estrogen metabolites and breast cancer: a case-control study.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1997;6(7):505-9.
1997: Joseph A Sparano; D Neuberg; J H Glick; N J Robert; Lee J Goldstein; G W Sledge; W Wood
Phase II trial of biweekly paclitaxel and cisplatin in advanced breast carcinoma: an Eastern Cooperative Oncology Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(5):1880-4.
1997: Kim Margolin; Michael Atkins; Joseph A Sparano; Jeffrey A Sosman; G Weiss; Michael Lotze; James Doroshow; James W Mier; K O'Boyle; Richard I Fisher; E Campbell; Joshua Rubin; D Federighi; SL Bursten
Prospective randomized trial of lisofylline for the prevention of toxicities of high-dose interleukin 2 therapy in advanced renal cancer and malignant melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(4):565-72.
1997: Joseph A Sparano; X Hu; Peter H Wiernik; Catherine Sarta; D M Reddy; Lawrence Hanau; David H Henry
Opportunistic infection and immunologic function in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma treated with chemotherapy.
Journal of the National Cancer Institute 1997;89(4):301-7.
1996: Joseph A Sparano; S Lipsitz; Scott Wadler; R Hansen; P W Bushunow; J Kirkwood; P J Flynn; Janice P Dutcher; Al B Benson
Phase II trial of prolonged continuous infusion of 5-fluorouracil and interferon-alpha in patients with advanced pancreatic cancer. Eastern Cooperative Oncology Group Protocol 3292.
American journal of clinical oncology 1996;19(6):546-51.
1996: Joseph A Sparano; Peter H Wiernik; X Hu; Catherine Sarta; Edward L Schwartz; R Soeiro; David H Henry; B Mason; Howard Ratech; Janice P Dutcher
Pilot trial of infusional cyclophosphamide, doxorubicin, and etoposide plus didanosine and filgrastim in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(11):3026-35.
1996: R Rosenblatt; SA Fineberg; Joseph A Sparano; Ronald Kaleya
Stereotactic core needle biopsy of multiple sites in the breast: efficacy and effect on patient care.
Radiology 1996;201(1):67-70.
1996: Joseph A Sparano; Catherine Sarta
Infection prophylaxis and antiretroviral therapy in patients with HIV infection and malignancy.
Current opinion in oncology 1996;8(5):392-9.
1996: Joseph A Sparano; N Robert; P Silverman; H Lazarus; U Malik; U Venkatraj; Catherine Sarta
Phase I trial of high-dose mitoxantrone plus cyclophosphamide and filgrastim in patients with advanced breast carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(9):2576-83.
1995: R J Levy; Joseph A Sparano; G Khan
Rhabdomyolysis: an unusual complication of cytotoxic chemotherapy.
Medical oncology (Northwood, London, England) 1995;12(4):219-22.
1995: Joseph A Sparano
Treatment of AIDS-related lymphomas.
Current opinion in oncology 1995;7(5):442-9.
1995: G W Sledge; N Robert; Joseph A Sparano; M Cogleigh; L J Goldstein; D Neuberg; eric rowinsky; C Baughman; W McCaskill-Stevens
Eastern Cooperative Oncology Group studies of paclitaxel and doxorubicin in advanced breast cancer.
Seminars in oncology 1995;22(3 Suppl 6):105-8.
1995: A Khalil; N Ciobanu; Joseph A Sparano; Rasim Gucalp; Janice P Dutcher; Peter H Wiernik
Pilot study of high-dose mitoxantrone and busulfan plus autologous bone transplantation in patients with advanced malignancies.
Bone marrow transplantation 1995;15(1):93-7.
1994: L Oleksowicz; M Strack; Janice P Dutcher; Ira I Sussman; G Caliendo; Joseph A Sparano; P H Wiernik
A distinct coagulopathy associated with interleukin-2 therapy.
British journal of haematology 1994;88(4):892-4.
1994: G W Sledge; N Robert; Joseph A Sparano; M Cobeligh; L J Goldstein; D Neuberg; eric rowinsky; C Baughman; W McCaskill-Stevens
Paclitaxel (Taxol)/doxorubicin combinations in advanced breast cancer: the Eastern Cooperative Oncology Group experience.
Seminars in oncology 1994;21(5 Suppl 8):15-8.
1994: Joseph A Sparano; Richard I Fisher; G R Weiss; Kim Margolin; Frederick R Aronson; M J Hawkins; Michael B Atkins; Janice P Dutcher; E R Gaynor; D H Boldt
Phase II trials of high-dose interleukin-2 and lymphokine-activated killer cells in advanced breast carcinoma and carcinoma of the lung, ovary, and pancreas and other tumors.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1994;16(3):216-23.
1994: Melody A Cobleigh; R F Berris; T Bush; Nancy E Davidson; N J Robert; Joseph A Sparano; D C Tormey; W C Wood
Estrogen replacement therapy in breast cancer survivors. A time for change. Breast Cancer Committees of the Eastern Cooperative Oncology Group.
JAMA : the journal of the American Medical Association 1994;272(7):540-5.
1994: Michael B Atkins; K R O'Boyle; Jeffrey A Sosman; G R Weiss; Kim Margolin; M L Ernest; K Kappler; James W Mier; Joseph A Sparano; Richard I Fisher
Multiinstitutional phase II trial of intensive combination chemoimmunotherapy for metastatic melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(8):1553-60.
1994: Joseph A Sparano; Peter H Wiernik; M Strack; A Leaf; N H Becker; Catherine Sarta; D Carney; R Elkind; M Shah; E S Valentine
Infusional cyclophosphamide, doxorubicin and etoposide in HIV-related non-Hodgkin's lymphoma: a follow-up report of a highly active regimen.
Leukemia & lymphoma 1994;14(3-4):263-71.
1994: Scott Wadler; L Tenteromano; L Cazenave; Joseph A Sparano; E S Greenwald; Alla Rozenblit; Ronald Kaleya; P H Wiernik
Phase II trial of echinomycin in patients with advanced or recurrent colorectal cancer.
Cancer chemotherapy and pharmacology 1994;34(3):266-9.
1994: Rasim Gucalp; Joseph A Sparano; J P Dutcher; P H Wiernik
Introduction to bone marrow transplant symposium held at the Albert Einstein Cancer Center at Bronx, NY, USA, March 23 to 25, 1994.
Medical oncology (Northwood, London, England) 1994;11(2):31-3.
1994: Peter H Wiernik; N T Sklarin; J P Dutcher; Joseph A Sparano; E S Greenwald
Adjuvant radiotherapy for breast cancer as a risk factor for the development of lung cancer.
Medical oncology (Northwood, London, England) 1994;11(3-4):121-5.
1993: Joseph A Sparano; Richard I Fisher; M Sunderland; Kim Margolin; M L Ernest; Mario Sznol; Michael B Atkins; Janice P Dutcher; K C Micetich; G R Weiss
Randomized phase III trial of treatment with high-dose interleukin-2 either alone or in combination with interferon alfa-2a in patients with advanced melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(10):1969-77.
1993: Joseph A Sparano; Scott Wadler; Leonard Liebes; N J Robert; Edward L Schwartz; Janice P Dutcher
Phase I trial of cyclophosphamide, doxorubicin, and 5-fluorouracil plus interferon-alpha 2b in patients with advanced breast cancer.
Cancer research 1993;53(15):3509-12.
1993: Joseph A Sparano; Scott Wadler; R B Diasio; R Zhang; Z Lu; Edward L Schwartz; Avi Einzig; Peter H Wiernik
Phase I trial of low-dose, prolonged continuous infusion fluorouracil plus interferon-alfa: evidence for enhanced fluorouracil toxicity without pharmacokinetic perturbation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(8):1609-17.
1993: Joseph A Sparano; Peter H Wiernik; A Leaf; Janice P Dutcher
Infusional cyclophosphamide, doxorubicin, and etoposide in relapsed and resistant non-Hodgkin's lymphoma: evidence for a schedule-dependent effect favoring infusional administration of chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(6):1071-9.
1993: Joseph A Sparano; Peter H Wiernik; M Strack; A Leaf; N Becker; E S Valentine
Infusional cyclophosphamide, doxorubicin, and etoposide in human immunodeficiency virus- and human T-cell leukemia virus type I-related non-Hodgkin's lymphoma: a highly active regimen.
Blood 1993;81(10):2810-5.
1993: E T Walpole; Janice P Dutcher; Joseph A Sparano; Rasim Gucalp; Avi Einzig; Elisabeth Paietta; N Ciobanu; K Grima; G Caliendo; G Cavasotto
Survival after phase II treatment of advanced renal cell carcinoma with taxol or high-dose interleukin-2.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1993;13(4):275-81.
1993: Joseph A Sparano; Lawrence J Brandt; J P Dutcher; J S DuBois; Michael B Atkins
Symptomatic exacerbation of Crohn disease after treatment with high-dose interleukin-2.
Annals of internal medicine 1993;118(8):617-8.
1993: Michael B Atkins; Joseph A Sparano; Richard I Fisher; G R Weiss; Kim Margolin; K I Fink; L Rubinstein; A Louie; James W Mier; Rasim Gucalp
Randomized phase II trial of high-dose interleukin-2 either alone or in combination with interferon alfa-2b in advanced renal cell carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(4):661-70.
1993: Joseph A Sparano; S Wadler; Edward L Schwartz; R Diasio
Clinical and pharmacological studies of interferon and chemotherapy in gastrointestinal and breast cancer.
International journal of clinical pharmacology research 1993;13(1):1-9.
1993: Joseph A Sparano; S Wadler
Increasing the efficacy of 5-fluorouracil with interferons: preclinical, clinical, and pharmacokinetic studies.
Advances in experimental medicine and biology 1993;339():125-31; discussion 165-7.
1992: Joseph A Sparano; K O'Boyle
The potential role for biological therapy in the treatment of breast cancer.
Seminars in oncology 1992;19(3):333-41.
1992: Joseph A Sparano; Rasim Gucalp; Josefina F Llena; F G Moser; P H Wiernik
Cerebral infection complicating systemic aspergillosis in acute leukemia: clinical and radiographic presentation.
Journal of neuro-oncology 1992;13(1):91-100.
1992: N Ciobanu; V Weinberg; Joseph A Sparano; G Zervos; J Walewski; M Spivack; P H Wiernik
Experience with autologous bone marrow harvesting and transfusion of marrow-derived red cells.
Transfusion 1992;32(3):231-4.
1991: Rasim Gucalp; N Ciobanu; Joseph A Sparano; M Motyl; P Carlisle; Peter H Wiernik
Disseminated aspergillosis after fungemia in a patient with extragonadal germ cell tumor undergoing autologous bone marrow transplantation.
Cancer 1991;68(8):1842-4.
1991: Joseph A Sparano; Janice P Dutcher; Ronald Kaleya; G Caliendo; J Fiorito; S Mitsudo; R Shechner; Scott Boley; Rasim Gucalp; N Ciobanu
Colonic ischemia complicating immunotherapy with interleukin-2 and interferon-alpha.
Cancer 1991;68(7):1538-44.
1991: Janice P Dutcher; E R Gaynor; D H Boldt; James Doroshow; M H Bar; Mario Sznol; James W Mier; Joseph A Sparano; Richard I Fisher; G Weiss
A phase II study of high-dose continuous infusion interleukin-2 with lymphokine-activated killer cells in patients with metastatic melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(4):641-8.
1991: Joseph A Sparano; J B Beckwith; S Mitsudo; Peter H Wiernik
Complete remission in refractory anaplastic adult Wilms' tumor treated with cisplatin and etoposide.
Cancer 1991;67(4):956-9.
1990: Mario Sznol; James W Mier; Joseph A Sparano; E R Gaynor; G R Weiss; Kim Margolin; M H Bar; M J Hawkins; Michael B Atkins; Janice P Dutcher
A phase I study of high-dose interleukin-2 in combination with interferon-alpha 2b.
Journal of biological response modifiers 1990;9(6):529-37.
1990: Joseph A Sparano; Edward L Schwartz; K M Salva; M F Pizzillo; Scott Wadler; Peter H Wiernik
Phase II trial of etoposide, doxorubicin (Adriamycin), and cisplatin (EAP regimen) in advanced gastric cancer.
American journal of clinical oncology 1990;13(5):374-8.
1990: Joseph A Sparano; P H Wiernik
Toxicity of etoposide, doxorubicin, and cisplatin in gastric cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(5):938-9.
1990: Joseph A Sparano; M Ramirez; Peter H Wiernik
Increasing recognition of corticosteroid-induced tumor lysis syndrome in non-Hodgkin's lymphoma.
Cancer 1990;65(5):1072-3.
1987: Joseph A Sparano; J Chang; S Trasi; C Bonanno
Treatment of the Budd-Chiari syndrome with percutaneous transluminal angioplasty. Case report and review of the literature.
The American journal of medicine 1987;82(4):821-8.
1986: Joseph A Sparano; E Ferranti
The acquired immunodeficiency syndrome and nonmenstrual toxic shock syndrome.
Annals of internal medicine 1986;105(2):300-1.